Larimar Therapeutics (LRMR) Non-Current Assets (2013 - 2026)
Larimar Therapeutics (LRMR) recorded Non-Current Assets of $4.63 million in Q2 2026, up 4.5% from $4.43 million a year earlier.
Powered by 
Analysis
Larimar Therapeutics (LRMR) Non-Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Larimar Therapeutics reported Non-Current Assets of $3.82 million, down 22.4% from FY2024.
- Annual Non-Current Assets has a five-year compound annual growth rate of -10.7% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $4.92 million in FY2024 (-14.6%), $5.76 million in FY2023 (+1.7%), $5.67 million in FY2022 (-12.3%) and $6.46 million in FY2021 (-4.0%).
- The Q2 2026 figure is the highest quarterly Non-Current Assets since Q1 2025.
- On a year-over-year basis, Non-Current Assets rose in two of the last seven quarters, with an average decline of 22.1%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 217.0% in Q1 2024, against a decline of 72.8% in Q1 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Larimar Therapeutics | 279.45 Mn | -389.49 Mn | - | 4.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.63 Mn |
| Mar 31, 2026 | 3.53 Mn |
| Dec 31, 2025 | 3.82 Mn |
| Sep 30, 2025 | 4.13 Mn |
| Jun 30, 2025 | 4.43 Mn |
| Mar 31, 2025 | 4.69 Mn |
| Dec 31, 2024 | 4.92 Mn |
| Sep 30, 2024 | 5.77 Mn |
| Jun 30, 2024 | 6.03 Mn |
| Mar 31, 2024 | 17.25 Mn |
| Dec 31, 2023 | 5.76 Mn |
| Sep 30, 2023 | 5.47 Mn |
| Jun 30, 2023 | 5.24 Mn |
| Mar 31, 2023 | 5.44 Mn |
| Dec 31, 2022 | 5.67 Mn |
| Sep 30, 2022 | 5.89 Mn |
| Jun 30, 2022 | 6.11 Mn |
| Mar 31, 2022 | 6.34 Mn |
| Dec 31, 2021 | 6.46 Mn |
| Sep 30, 2021 | 6.69 Mn |
API Access
Larimar Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();